Fuchs M - Search Results

1

Wongso D, Fuchs M, Plütschow A, Klimm B, Sasse S, Hertenstein B, Maschmeyer G, Vieler T, Dührsen U, Lindemann W, Aulitzky W, Diehl V, Borchmann P, Engert A. Wongso D, et al. Among authors: fuchs m. J Clin Oncol. 2013 Aug 1;31(22):2819-24. doi: 10.1200/JCO.2012.47.9774. Epub 2013 Jun 24. J Clin Oncol. 2013. PMID: 23796987 Clinical Trial.

2

Using at least 5x10(6)/kg CD34+ cells for autologous stem cell transplantation significantly reduces febrile complications and use of antibiotics after transplantation.

Scheid C, Draube A, Reiser M, Schulz A, Chemnitz J, Nelles S, Fuchs M, Winter S, Wickramanayake PD, Diehl V, Söhngen D. Scheid C, et al. Among authors: fuchs m. Bone Marrow Transplant. 1999 Jun;23(11):1177-81. doi: 10.1038/sj.bmt.1701748. Bone Marrow Transplant. 1999. PMID: 10382958

3

High platelet contamination in progenitor cell concentrates results in significantly lower CD34+ yield after immunoselection.

Reiser M, Draube A, Scheid C, Fuchs M, Josting A, Diehl V, Söhngen D. Reiser M, et al. Among authors: fuchs m. Transfusion. 2000 Feb;40(2):178-81. doi: 10.1046/j.1537-2995.2000.40020178.x. Transfusion. 2000. PMID: 10686001

4

Fatal thrombotic thrombocytopenic purpura as a rare complication following allogeneic stem cell transplantation.

Chemnitz J, Fuchs M, Blau W, Hartmann P, Wickenhauser C, Scheid C, Schulz A, Diehl V, Söhngen D. Chemnitz J, et al. Among authors: fuchs m. Ann Hematol. 2000 Sep;79(9):527-9. doi: 10.1007/s002770000187. Ann Hematol. 2000. PMID: 11043426

5

Randomized, double-blind, controlled study of glycyl-glutamine-dipeptide in the parenteral nutrition of patients with acute leukemia undergoing intensive chemotherapy.

Scheid C, Hermann K, Kremer G, Holsing A, Heck G, Fuchs M, Waldschmidt D, Herrmann HJ, Söhngen D, Diehl V, Schwenk A. Scheid C, et al. Among authors: fuchs m. Nutrition. 2004 Mar;20(3):249-54. doi: 10.1016/j.nut.2003.11.018. Nutrition. 2004. PMID: 14990264 Clinical Trial.

6

Current strategies and new approaches in the treatment of Hodgkin's lymphoma.

Fuchs M, Diehl V, Re D. Fuchs M, et al. Pathobiology. 2006;73(3):126-40. doi: 10.1159/000095559. Pathobiology. 2006. PMID: 17085957 Review.

7

The aberrant coexpression of several receptor tyrosine kinases is largely restricted to EBV-negative cases of classical Hodgkin's lymphoma.

Renné C, Hinsch N, Willenbrock K, Fuchs M, Klapper W, Engert A, Küppers R, Hansmann ML, Bräuninger A. Renné C, et al. Among authors: fuchs m. Int J Cancer. 2007 Jun 1;120(11):2504-9. doi: 10.1002/ijc.22511. Int J Cancer. 2007. PMID: 17330841 Free article.

8

Early, intermediate and advanced Hodgkin's lymphoma: modern treatment strategies.

Diehl V, Fuchs M. Diehl V, et al. Among authors: fuchs m. Ann Oncol. 2007 Jul;18 Suppl 9:ix71-9. doi: 10.1093/annonc/mdm297. Ann Oncol. 2007. PMID: 17631599 Free article. Review. No abstract available.

9

CNS involvement in Hodgkin's lymphoma.

Re D, Fuchs M, Schober T, Engert A, Diehl V. Re D, et al. Among authors: fuchs m. J Clin Oncol. 2007 Jul 20;25(21):3182. doi: 10.1200/JCO.2007.12.5088. J Clin Oncol. 2007. PMID: 17634503 No abstract available.

10

Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?

Diehl V, Fuchs M; GHSG. Diehl V, et al. Among authors: fuchs m. Transfus Apher Sci. 2007 Aug;37(1):37-41. doi: 10.1016/j.transci.2007.04.004. Epub 2007 Aug 21. Transfus Apher Sci. 2007. PMID: 17714996 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,576 results

Search Page